Lung cancer is the leading cause of cancer-related deaths worldwide. Patients with
resectable NSCLC are often treated with surgery and adjuvant chemotherapy. However …

Background In a previous meta-analysis, we identified a survival benefit from neoadjuvant
chemotherapy or chemoradiotherapy before surgery in patients with resectable …

Cancers originating in the esophagus or esophagogastric junction constitute a major global
health problem. Esophageal cancers are histologically classified as squamous cell …

Background Clinical benefit of neoadjuvant immunotherapy in resectable esophageal
squamous cell carcinoma (ESCC). remains unclear. This study evaluated the efficacy and …

Background Neoadjuvant chemotherapy before surgery improves survival compared with
surgery alone for patients with oesophageal cancer. The OE05 trial assessed whether …

Background Resectable oesophageal cancer is often treated with surgery alone or with
preoperative (neoadjuvant) chemoradiotherapy or chemotherapy. We aimed to clarify the …

Purpose: Emerging evidence indicates that gut microbiome plays a crucial role in the cancer
pathogenesis. Although Fusobacterium nucleatum (F. nucleatum) is associated with poor …

Purpose: We performed a multicenter randomized controlled trial to determine whether
postoperative adjuvant chemotherapy improves outcome in patients with esophageal …

Objective: This network meta-analysis compared overall survival after neoadjuvant or
adjuvant chemotherapy (CT), radiotherapy (RT), or combinations of both …

INTRODUCTION: Preoperative chemotherapy (CT) and preoperative chemoradiation
therapy (CRT) for resectable oesophageal cancer have been shown to improve overall …